22h agoMarketWatchBULLISH 63General
Archived explainer. For the current picture see today's RVTY page.
Why Is REVVITY INC (RVTY) Stock Up Today?
By the Top Tier Newswire AI Desk · September 25, 2026 at 9:30 AM ET · reviewed against 3 wire stories
REVVITY INC (RVTY) is up +6.03% in the latest session. Our newswire has captured 3 stories on RVTY across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why RVTY stock is up today
Revvity Inc. stock rose by 6.03% to $150.68 in early trading on the announcement of a new product launch and positive market momentum. The stock opened with a small gap up from the previous close and saw a brief pullback before stabilizing near its opening price. The move appears to be driven by the company’s recent introduction of an innovative diagnostic solution.
What Happened
Revvity Inc. announced the launch of its GSP T1D 3plex kit, a CE-IVDR-certified solution for the early detection of Type 1 Diabetes. The kit utilizes dried blood spots on Revvity’s newborn-screening instrument and is initially available in Europe. The product is not FDA-cleared, but the company emphasized its potential to expand its market reach in the diagnostics sector. This development was highlighted in multiple reports, including one from The Fly and another from StockTitan. The stock’s performance also outpaced that of its competitors on the day, as noted in a MarketWatch report.
What The Data Shows
The stock opened at $152.00, slightly above the previous close of $150.68, and reached a session high of $152.00 within the first hour of trading. It then dipped to a low of $149.52 before settling near $150.76. The volume so far has been 0.0M shares, which is 0.0x the 3-month daily average. The stock is currently trading within its 52-week range of $81.22 to $152.26 and has printed 52 fresh 52-week highs on September 24. The company has a market cap of $15.9B, a P/E ratio of 72.0, and trailing twelve-month revenue growth of 4.1%.
What To Watch
Revvity’s Q2 2026 earnings call transcript was recently released, and the company’s performance in the coming quarters will be a key focus for investors. Additionally, the stock’s ability to maintain its recent momentum amid mixed insider selling activity will be closely monitored.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
RVTY by the numbers
Last: $150.68Session: +6.03%Coverage: 3 stories / 3 sourcesAI sentiment: 63/100 (bullish)Mkt cap: $15.9BP/E: 72.052w: $81.22 to $152.26
The headlines behind the move
1d agoThe FlyBULLISH 63Product/PR
Revvity launches GSP T1D 3plex kit
1d agoStockTitanBULLISH 63Product/PR
Revvity Launches IVDR-Certified Solution for Early Detection of Type 1 Diabetes
The CE-IVDR-certified kit uses dried blood spots on Revvity’s newborn-screening instrument and will initially be available in Europe; it is not FDA-cleared.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on RVTY: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier RVTY move explainers: 2026-09-25 · 2026-09-24 · 2026-09-16 · 2026-09-15